Todd Davis, CEO, Director at Ligand Pharma, holds 120.16K shares in Ligand Pharma (Ticker: LGND), holds 29.17K shares in Chromocell Therapeutics Corp (Ticker: CHRO), holds 125.91K shares in Vaxart (Ticker: VXRT). Most recently, Todd Davis Bought ― shares of Ligand Pharma on Mar 27, 2024 for an estimated value of 919.15K.